Literature DB >> 24338441

CCN1 promotes vascular endothelial growth factor secretion through αvβ 3 integrin receptors in breast cancer.

Ingrid Espinoza1, Javier A Menendez, Chandra Mohan Kvp, Ruth Lupu.   

Abstract

Entities:  

Year:  2013        PMID： 24338441      PMCID： PMC3972397          DOI： 10.1007/s12079-013-0214-6

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN： 1873-9601            Impact factor:   5.782


× No keyword cloud information.
  30 in total

1.  Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.

Authors:  D Xie; K Nakachi; H Wang; R Elashoff; H P Koeffler
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

Review 2.  Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.

Authors:  A Saaristo; T Karpanen; K Alitalo
Journal:  Oncogene       Date:  2000-12-11       Impact factor: 9.867

3.  CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth.

Authors:  A M Babic; M L Kireeva; T V Kolesnikova; L F Lau
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo.

Authors:  T Shimo; T Nakanishi; T Nishida; M Asano; M Kanyama; T Kuboki; T Tamatani; K Tezuka; M Takemura; T Matsumura; M Takigawa
Journal:  J Biochem       Date:  1999-07       Impact factor: 3.387

Review 5.  Clinical significance of determination of surrogate markers of angiogenesis in breast cancer.

Authors:  G Gasparini
Journal:  Crit Rev Oncol Hematol       Date:  2001-02       Impact factor: 6.312

6.  Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease.

Authors:  D Xie; C W Miller; J O'Kelly; K Nakachi; A Sakashita; J W Said; J Gornbein; H P Koeffler
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

Review 7.  The prognostic role of angiogenesis in breast cancer.

Authors:  R D Leek
Journal:  Anticancer Res       Date:  2001 Nov-Dec       Impact factor: 2.480

Review 8.  Vascular endothelial growth factor in breast cancer: biologic and therapeutic aspects.

Authors:  George W Sledge
Journal:  Semin Oncol       Date:  2002-06       Impact factor: 4.929

9.  CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.

Authors:  Cristiane G Lin; Shr-Jeng Leu; Ningyu Chen; Christopher M Tebeau; Shao-Xia Lin; Cho-Yau Yeung; Lester F Lau
Journal:  J Biol Chem       Date:  2003-04-13       Impact factor: 5.157

10.  Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.

Authors:  Richard A Dean; Georgina S Butler; Yamina Hamma-Kourbali; Jean Delbé; David R Brigstock; José Courty; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272
View more
  7 in total

1.  In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.

Authors:  Samantha Guillemette; Charlène Rico; Philippe Godin; Derek Boerboom; Marilène Paquet
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-08-18       Impact factor: 2.673

2.  Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness.

Authors:  Ingrid Espinoza; Chandra Kurapaty; Cheol-Hong Park; Travis Vander Steen; Celina G Kleer; Elizabeth Wiley; Alfred Rademaker; Elisabet Cuyàs; Sara Verdura; Maria Buxó; Carol Reynolds; Javier A Menendez; Ruth Lupu
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

3.  Dual roles of CCN proteins in breast cancer progression.

Authors:  Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2016-08-12       Impact factor: 5.782

4.  CCN1 induces oncostatin M production in osteoblasts via integrin-dependent signal pathways.

Authors:  Cheng-Yu Chen; Chen-Ming Su; Yuan-Li Huang; Chun-Hao Tsai; Lih-Jyh Fuh; Chih-Hsin Tang
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

5.  Indomethacin enhances anti-tumor efficacy of a MUC1 peptide vaccine against breast cancer in MUC1 transgenic mice.

Authors:  Jennifer M Curry; Dahlia M Besmer; Timothy K Erick; Nury Steuerwald; Lopamudra Das Roy; Priyanka Grover; Shanti Rao; Sritama Nath; Jacob W Ferrier; Robert W Reid; Pinku Mukherjee
Journal:  PLoS One       Date:  2019-11-06       Impact factor: 3.240

6.  Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells.

Authors:  Ingrid Espinoza; Lin Yang; Travis Vander Steen; Luciano Vellon; Elisabet Cuyàs; Sara Verdura; Lester Lau; Javier A Menendez; Ruth Lupu
Journal:  Aging (Albany NY)       Date:  2022-02-11       Impact factor: 5.682

Review 7.  Potential Role of CCN Proteins in Breast Cancer: Therapeutic Advances and Perspectives.

Authors:  Kazi Ahsan Ahmed; Tasnin Al Hasib; Shamrat Kumar Paul; Md Saddam; Afsana Mimi; Abu Saim Mohammad Saikat; Hasan Al Faruque; Md Ataur Rahman; Md Jamal Uddin; Bonglee Kim
Journal:  Curr Oncol       Date:  2021-11-26       Impact factor: 3.677
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.